1. Allahbadia GN, Merchant R. Polycystic ovary syndrome and impact on health. Middle East Fertil Soc J 2011; 16: 19-37. [
DOI:10.1016/j.mefs.2010.10.002]
2. Tsilchorozidou T, Overton C, Conway GS. The pathophysiology of polycystic ovary syndrome. Clin Endocrinol 2004; 60: 1-17. [
DOI:10.1046/j.1365-2265.2003.01842.x]
3. Patel K, Coffler MS, Dahan MH, Malcom PJ, Deutsch A, Chang RJ. Relationship of GnRH-stimulated LH release to episodic LH secretion and baseline endocrine-metabolic measures in women with polycystic ovary syndrome. Clin Endocrinol 2004; 60: 67-74. [
DOI:10.1111/j.1365-2265.2004.01945.x]
4. Pasquali R, Zanotti L, Fanelli F, Mezzullo M, Fazzini A, Morselli Labate AM, et al. Defining hyperandrogenism in women with polycystic ovary syndrome: a challenging perspective. J Clin Endocrinol Metab 2016; 101: 2013-2022. [
DOI:10.1210/jc.2015-4009]
5. Trivax B, Azziz R. Diagnosis of polycystic ovary syndrome. Clin Obstet Gynecol 2007; 50: 168-177. [
DOI:10.1097/GRF.0b013e31802f351b]
6. Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, et al. American association of clinical endocrinologists, american college of endocrinology, and androgen excess and PCOS society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome-part 1. Endocr Pract 2015; 21: 1291-1300. [
DOI:10.4158/EP15748.DSC]
7. Shokeir T, El-Kannishy G. Rosiglitazone as treatment for clomiphene citrate-resistant polycystic ovary syndrome: factors associated with clinical response. J Womens Health 2008; 17: 1445-1452. [
DOI:10.1089/jwh.2008.0812]
8. Maruthur NM, Tseng E, Hutfless S, Wilson LM, Suarez-Cuervo C, Berger Z, et al. Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med 2016; 164: 740-751. [
DOI:10.7326/M15-2650]
9. Brettenthaler N, De Geyter C, Huber PR, Keller U. Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004; 89: 3835-3840. [
DOI:10.1210/jc.2003-031737]
10. Hasani-Ranjbar S, Larijani B. Medicinal plants as potential new target drugs in endocrine disorders-review article. Iran J Public Health 2014; 43: 24-34.
11. Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res 2003; 17: 299-305. [
DOI:10.1002/ptr.1309]
12. Burits M, Bucar F. Antioxidant activity of Nigella sativa essential oil. Phytother Res 2000; 14: 323-328.
https://doi.org/10.1002/1099-1573(200008)14:5<323::AID-PTR621>3.0.CO;2-Q [
DOI:10.1002/1099-1573(200008)14:53.0.CO;2-Q]
13. Kanter M, Coskun O, Kalayci M, Buyukbas S, Cagavi F. Neuroprotective effects of Nigella sativa on experimental spinal cord injury in rats. Hum Exp Toxicol 2006; 25: 127-133. [
DOI:10.1191/0960327106ht608oa]
14. Ait Mbarek L, Ait Mouse H, Elabbadi N, Bensalah M, Gamouh A, Aboufatima R, et al. Anti-tumor properties of blackseed, (Nigella sativa L.) extracts. Braz J Med Biol Res 2007; 40: 839-847. [
DOI:10.1590/S0100-879X2006005000108]
15. AL-Hader A, Agel M, Hasan Z. Hypoglycemic effects of the volatile oil of Nigella sativa seeds. Int J Pharmacog 1993; 31: 96-100. [
DOI:10.3109/13880209309082925]
16. El-dian EG, Helal E, Mostafa AM. Effect of Nigella sativa extract on some physiological parameters and histological changes in alloxan-induced diabetic albino rats. Egypt J Exp Biol (Zool) 2006; 2: 233-240.
17. Parandin R, Yousofvand N, Ghorbani R. The enhancing effects of alcoholic extract of Nigella sativa seed on fertility potential, plasma gonadotropins and testosterone in male rats. Iran J Reprod Med 2012; 10: 355-362.
18. Kamarzaman S, Shaban M, Abdul Rahman S. The prophylactic effect of Nigella Sativa against cyclophosphamide in the ovarian follicles of matured adult mice: A preliminary study. J Anim Plant Sci 2014; 24: 81-88.
19. Loeffler HH, McDougald CH. Estimation of cholesterol in serum by means of improved technics. Am J Clin Pathol 1963; 39: 311-315. [
DOI:10.1093/ajcp/39.3_ts.311]
20. Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoprotein from human serum by precipitation with polyanions. J Lipid Res 1970; 11: 583-595.
21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
22. Gottfried SP, Rosenberg B. Improved manual spectrophotometric procedure for determination of serum triacylglycerols. Clin Chem 1973; 19: 1077-1078.
23. Suvarna KS, Layton Ch, Bancroft JD. Bancroft's Theory and Practice of Histological Techniques. Sixth ed. New York, London, San Francisco Tokyo: Churchill Livingstone; 2008.
24. Williams CJ, Erickson GF. Morphology and physiology of the ovary. Endotext 2003: 51-58.
25. Committee for the update of the guide for the care and use of laboratory animals. Guide for the care and use of laboratory animals. Washington, DC; USA: National Academy Press; 1996.
26. Corbett SJ, McMichael AJ, Prentice AM. Type 2 diabetes, cardiovascular disease, and the evolutionary paradox of the polycystic ovary syndrome: a fertility first hypothesis. Am J Hum Biol 2009; 21: 587-598. [
DOI:10.1002/ajhb.20937]
27. Simard M, Brawer JR, Farookhi R. An intractable, ovary-independent impairment in hypothalamo-pituitary function in the estradiol-valerate-induced polycystic ovarian condition in the rat. Biol Reprod 1987; 36: 1229-1237. [
DOI:10.1095/biolreprod36.5.1229]
28. Stener-Victorin E, Ploj K, Larsson BM, Holmang A. Rats with steroid-induced polycystic ovaries develop hypertension and increased sympathetic nervous system activity. Reprod Biol Endocrinol 2005; 3: 44-54. [
DOI:10.1186/1477-7827-3-44]
29. Shi D, Vine DF. Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk. Fertil Steril 2012; 98: 185-193. [
DOI:10.1016/j.fertnstert.2012.04.006]
30. Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 2006; 34: D668-D672. [
DOI:10.1093/nar/gkj067]
31. Brettenthaler N, De Geyter C, Huber PR, Keller U. Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004; 89: 3835-3840. [
DOI:10.1210/jc.2003-031737]
32. Marchetti P, Del Guerra S, Marselli L, Lupi R, Masini M, Pollera M, et al. Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab 2004; 89: 5535-5541. [
DOI:10.1210/jc.2004-0150]
33. Arslanian SA, Lewy V, Danadian K, Saad R. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance. J Clin Endocrinol Metab 2002; 87: 1555-1559. [
DOI:10.1210/jcem.87.4.8398]
34. Lee MS, Kang SK, Lee BC, Hwang WS. The beneficial effects of insulin and metformin on in vitro developmental potential of porcine oocytes and embryos. Biol Reprod 2005; 73: 1264-1268. [
DOI:10.1095/biolreprod.105.041186]
35. Kaatabi H, Bamosa AO, Badar A, Al-Elq A, Abou-Hozaifa B, Lebda F, et al. Nigella sativa iImproves glycemic control and ameliorates oxidative stress in patients with type 2 diabetes mellitus: placebo controlled participant blinded clinical trial. PLoS One 2015; 10: e0113486. [
DOI:10.1371/journal.pone.0113486]
36. Samarji R, Balbaa M. Anti-diabetic activity of different oils through their effect on arylsulfatases. J Diabetes Metab Disord 2014; 13: 116-123. [
DOI:10.1186/s40200-014-0116-z]
37. Kaatabi H, Bamosa AO, Lebda FM, Al Elq AH, Al-Sultan AI. Favorable impact of Nigella sativa seeds on lipid profile in type 2 diabetic patients. J Fam Commun Med 2012; 19: 155-161. [
DOI:10.4103/2230-8229.102311]
38. Mukhallad AM, Mohamad MJ, Mohamad, Hatham D. Effects of black seeds (Nigella sativa) on spermatogenesis and fertility of male albino rats. Res J Med Med Sci 2009; 4: 386-390.
39. Al-Sa'aidi JAA, Al-Khuzai ALD, Al-Zobaydi NFH. Effect of alcoholic extract of Nigella sativa on fertility in male rats. Iraq J Vet Sci 2009; 23: 123-128.